{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-000150","form_type":"8-K","ticker":"AEMD","cik":"0000882291","company_name":"AETHLON MEDICAL INC","filed_at":"2025-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.648027+00:00","generated_at":"2026-05-28T07:25:57.352932+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aethlon Medical gets 180-day Nasdaq extension through June 23, 2025 for bid price rule","bullets":["Received 180-day extension from Nasdaq until June 23, 2025 to regain $1.00 minimum bid price compliance.","Stock must close at $1.00+ for at least 10 consecutive trading days to regain compliance; non-compliant since June 2024.","Failure to regain compliance by June 23, 2025 may lead to delisting; Company could appeal to hearings panel.","Company intends to monitor bid price and consider available options; no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-000150","json":"https://secwatch.observer/filing/0001683168-25-000150.json","markdown":"https://secwatch.observer/filing/0001683168-25-000150.md","text":"https://secwatch.observer/filing/0001683168-25-000150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882291/000168316825000150/0001683168-25-000150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882291/000168316825000150/aethlon_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T07:25:57.352932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b4757bd22433d48076322a25b6015abbf60e713d","claim":"AETHLON MEDICAL INC received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"January 7, 2025, the Company received a letter from Nasdaq (the “Extension Notice”) advising that the Company has been granted a 180-day extension, or until June 23, 2025, to regain compliance with the Minimum Bid Price","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/882291/000168316825000150/0001683168-25-000150-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}